Neuroleptic
Mostrando 13-24 de 110 artigos, teses e dissertações.
-
13. Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice
Previous studies have shown that rats withdrawn from long-term treatment with dopamine receptor blockers exhibit dopaminergic supersensitivity, which can be behaviorally evaluated by enhanced general activity observed in an open-field. Recently, it has been reported that co-treatment with the non-benzodiazepine anxiolytic buspirone attenuates the development
Brazilian Journal of Medical and Biological Research. Publicado em: 2002-02
-
14. Esquizofrenia e ansiedade : um estudo clinico sobre ansiedade em pacientes esquizofrenicos
A study on anxiety in schizophrenic patinets, envolving a cross sectional observation of 40 patients fulfilling the DSM-IV diagnostic criteria for schizophrenia, is reported. Theses patients were not in acute episode and the clinical follow-up was done in four day-hospitals in the municipality of São Paulo. Both sexes were included in the study, independent
Publicado em: 1997
-
15. Linguagem e isolamento social no mal de parkinson
This research has the aim of studying the relationship between language and Parkinson s disease social isolation. Given the frequency of symptons of depression that follows this disease and the importance of the language in social relations, we examine a group of 17 patients, 9 of them being non-depressive and 8 depressive, in the age of 48 and 77 years old,
Publicado em: 1994
-
16. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
Parkinsonism is a common complication of neuroleptic drug use; however, the pathophysiology of the persistence of parkinsonian symptoms after withdrawal of neuroleptic drugs is poorly understood. Twenty patients with neuroleptic induced parkinsonism were studied by high field MRI. Persistence of symptoms was associated with different findings depending on th
-
17. Neuroleptic malignant syndrome: case report and discussion
WE REPORT A CASE INVOLVING AN 81-YEAR-OLD man with schizoaffective disorder who presented with neuroleptic malignant syndrome (NMS) after an increase in his neuroleptic dose. NMS, a rare but potentially fatal complication of neuroleptic medications (e.g., antipsychotics, sedatives and antinauseants), is characterized by hyperthermia, muscle rigidity, an elev
-
18. Neuroleptic Malignant Syndrome: A Primary Care Perspective
In recent years, there has been an increased use of neuroleptic agents in the primary care setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy that can be missed if not suspected. This manuscript reviews the diagnosis and management of NMS in the primary care setting. There is a lack of prospective data, and most of th
Physicians Postgraduate Press.
-
19. Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs.
Neuroleptic medication in three patients with prior isolated postural arm tremor led to a conspicuous deterioration; the postural tremor increased in amplitude, tremor appeared at rest, and other signs of mild parkinsonism developed. Withdrawal of neuroleptic drugs led to improvement in tremor and disappearance of parkinsonism. Positron emission tomography s
-
20. Neuroleptic malignant syndrome and hypothyroidism.
Two patients with primary hypothyroidism who developed neuroleptic malignant syndrome (NMS) are described. Thyroid disease might predispose to NMS by altering brain dopamine metabolism.
-
21. Neuroleptic drugs attenuate calcium influx and tension development in rabbit thoracic aorta: effects of pimozide, penfluridol, chlorpromazine, and haloperidol.
This study was designed to determine whether neuroleptic drugs have calcium channel blocking activity in isolated rings of rabbit thoracic aorta. The results confirm previous findings that pimozide and penfluridol are calcium channel blockers. However, the data do not support the conclusion that these agents are selective for the voltage-sensitive calcium ch
-
22. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Twenty six consecutive patients with neuroleptic-induced Parkinson's syndrome (NIPS) are described. Their median age was 61 years, 60% were female, and most had received chronic neuroleptic medication for psychiatric indications. The clinical features were indistinguishable from idiopathic Parkinson's disease, except for the presence of co-existing orofacial
-
23. Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury.
A selective subtotal cerebellar neuronal degeneration was found in a patient who died 4 1/2 months after suffering neuroleptic malignant syndrome (NMS), a rare, potentially fatal disorder associated with neuroleptic medications. It is suggested that the cerebellar neuronal degeneration in this case was due to hyperpyrexia, a cardinal clinical feature of NMS.
-
24. Serum iron and transferrin in acute neuroleptic induced akathisia.
Thirty acute psychiatric patients were examined prospectively at the beginning of neuroleptic treatment for acute psychotic symptoms and on average 16 days later. Two alternative hypotheses were examined: 1) neuroleptic treatment affects the levels of serum iron and transferrin; 2) acute akathisia developing during the initial few weeks of treatment is assoc